Honeywell Aerospace Backlog Supports Long-Term Story, But Near-Term Risks Keep Rating at Wait

What happened

The Seeking Alpha article highlights Honeywell Aerospace's $18.2B backlog, double-digit order growth, and reaffirmed 2030 targets, but acknowledges supply constraints, spin-related costs, and elevated leverage are suppressing near-term earnings. This aligns with the master report's view that aerospace demand is robust but not translating cleanly into margins, as evidenced by the 4Q25 ex-Bombardier margin decline. The article's focus on 2027 defense play suggests the market may be looking past near-term execution risks, but our analysis shows cash quality and separation timing remain unresolved. Specifically, the company's 2026 FCF guidance still relies on ~$1.9B in adjustments, and the Q3 2026 aerospace separation has yet to clear SEC effectiveness. Therefore, we see no reason to change our WAIT rating: demand strength is already reflected in the stock's 29x P/E, and we await either a pullback to ~$220 or clearer disclosure on standalone leverage and normalized cash flow.

Implication

The news confirms Honeywell's aerospace franchise has durable demand, but the market is already pricing in a clean separation and sustained strength at a rich multiple. Investors should be wary of buying into the 2027 defense narrative without concrete evidence that supply bottlenecks are easing and spin costs are temporary. The key catalysts remain the June 3 Investor Day (now past) and Form 10 effectiveness; if these milestones slip, the stock could de-rate sharply. Conversely, if management delivers a credible normalized cash framework and the separation closes on time, upside to $280 is possible. Until then, we maintain a WAIT rating and prefer to accumulate on weakness near $220.

Thesis delta

No material change to the thesis. The article adds color on aerospace's sustained demand but does not address the two core risks: separation timeline uncertainty and cash-quality adjustments. The WAIT rating stands, with entry target at $220 and re-assessment window of 3-6 months.